Kowa   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Nagoya Japan (1894)

Organization Overview

First Clinical Trial
2005
NCT00257686
First Marketed Drug
2009
pitavastatin (livalo)
First NDA Approval
2009
pitavastatin (livalo)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

IMAGE TECHNOLOGIES INC. | KOWA CO | Kowa Company, Ltd. | Kowa Pharmaceuticals America, Inc. | Kowa Pharma Development Co. | KOWA PHARMS | Kowa Research Europe | Kowa Research Europe (KRE) | Kowa Research Institute, Inc.